Literature DB >> 1914064

The anaesthetic management of a patient with a phaeochromocytoma and acute stroke.

J M Fox1, P H Manninen.   

Abstract

A case is reported of a young woman in whom the diagnosis of a phaeochromocytoma was made after a major stroke. Preoperative preparation included the introduction of phenoxybenzamine, 10 mg.day-1, and propranolol, 80 mg.day-1, over a two-week period. The presence of cerebrovascular disease and the marked orthostatic changes in blood pressure and heart rate to low-dose phenoxybenzamine prevented the establishment of full alpha blockade. Incomplete alpha blockade probably contributed to the hypertensive response to manipulation of the tumour (220/150 mmHg) and hypotension occurred after removal of the tumour (80/45 mmHg). An anaesthetic technique was chosen to provide haemodynamic stability as well as protection against cerebral ischaemia. Invasive haemodynamic monitoring, a four-channel processed electroencephalograph and somatosensory evoked potentials were used to accomplish these goals.

Entities:  

Mesh:

Year:  1991        PMID: 1914064     DOI: 10.1007/BF03008459

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  16 in total

1.  Segmental cerebral arterial constriction associated with pheochromocytoma: report of a case with arteriograms.

Authors:  F S ARMSTRONG; G J HAYES
Journal:  J Neurosurg       Date:  1961-11       Impact factor: 5.115

2.  The effect of Pa CO2 on the metabolism of ischemic brain in squirrel monkeys.

Authors:  J D Michenfelder; T M Sundt
Journal:  Anesthesiology       Date:  1973-05       Impact factor: 7.892

3.  Pulmonary artery pressure monitoring in patients with pheochromocytoma.

Authors:  F G Mihm
Journal:  Anesth Analg       Date:  1983-12       Impact factor: 5.108

4.  The neurologist's experience with pheochromocytoma. A review of 100 cases.

Authors:  J E Thomas; E D Rooke; W F Kvale
Journal:  JAMA       Date:  1966-09-05       Impact factor: 56.272

Review 5.  Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management.

Authors:  C J Hull
Journal:  Br J Anaesth       Date:  1986-12       Impact factor: 9.166

6.  Monitoring of somatosensory evoked responses during carotid endarterectomy.

Authors:  O N Markand; R S Dilley; S S Moorthy; C Warren
Journal:  Arch Neurol       Date:  1984-04

7.  Prognostic value of computerized EEG analysis during carotid endarterectomy.

Authors:  I J Rampil; J A Holzer; D O Quest; S H Rosenbaum; J W Correll
Journal:  Anesth Analg       Date:  1983-02       Impact factor: 5.108

8.  The effects of dextrose infusion and head position on neurologic outcome after complete cerebral ischemia in primates: examination of a model.

Authors:  W L Lanier; K J Stangland; B W Scheithauer; J H Milde; J D Michenfelder
Journal:  Anesthesiology       Date:  1987-01       Impact factor: 7.892

9.  Pheochromocytoma and sudden death as a result of cerebral infarction in Turner's syndrome: report of a case.

Authors:  A S Knisely; K Sweeney; M W Ambler
Journal:  J Forensic Sci       Date:  1988-11       Impact factor: 1.832

10.  Pheochromocytoma: current status and changing trends.

Authors:  J A van Heerden; S G Sheps; B Hamberger; P F Sheedy; J G Poston; W H ReMine
Journal:  Surgery       Date:  1982-04       Impact factor: 3.982

View more
  3 in total

Review 1.  Pheochromocytoma as an endocrine emergency.

Authors:  Frederieke M Brouwers; Jacques W M Lenders; Graeme Eisenhofer; Karel Pacak
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Reversible cerebral ischemia in patients with pheochromocytoma.

Authors:  F S Lehmann; P Weiss; R Ritz; F Harder; J J Staub
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

Review 3.  Management of hypertension in intrapericardial paraganglioma.

Authors:  Nicola Rotolo; Andrea Imperatori; Alessandro Bacuzzi; Valentina Conti; Massimo Castiglioni; Lorenzo Dominioni
Journal:  Int J Hypertens       Date:  2014-02-13       Impact factor: 2.420

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.